StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) stock

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)

Close on Nov 18, 2026Market cap $13.37MP/E –Yield –

Matinas BioPharma profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Matinas BioPharma's profit margin for the twelve months ending Dec 31, 2023 was -2093.2%. For fiscal 2023 it was -2093.2%, against -658.6% the year before. The highest annual figure on record is -658.6% in fiscal 2022.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-2093.2%−1434.6
FY2022Dec 31, 2022-658.6%+69895.9
FY2021Dec 31, 2021-70554.5%−56377.6
FY2020Dec 31, 2020-14177.0%+5166.4
FY2019Dec 31, 2019-19343.4%−7583.0
FY2018Dec 31, 2018-11760.4%−1414.5
FY2017Dec 31, 2017-10345.9%−5648.9
FY2015Dec 31, 2015-4697.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2023Mar 31, 2023-503.0%+14366.1
Q4 FY2022Dec 31, 2022-341.9%+9803.5
Q3 FY2022Sep 30, 2022-513.8%+5172.6
Q2 FY2022Jun 30, 2022-557.2%+3166.9
Q1 FY2021Mar 31, 2021-14869.1%−11071.2
Q4 FY2020Dec 31, 2020-10145.4%+3583.4
Q3 FY2020Sep 30, 2020-5686.5%+2392.7
Q2 FY2019Jun 30, 2019-3724.1%+3835.5
Q2 FY2018Jun 30, 2018-3797.9%+5037.5
Q1 FY2018Mar 31, 2018-13728.8%+16307.3
Q4 FY2017Dec 31, 2017-8079.1%–
Q3 FY2017Sep 30, 2017-7559.6%–
Q2 FY2017Jun 30, 2017-8835.4%–
Q1 FY2017Mar 31, 2017-30036.2%–

More Matinas BioPharma figures

See a number that looks wrong?